The European Commission

R&D

We have seen a boom in biotech initial public offerings over the last two years, but many of Europe’s offerings have migrated to the United States.

News

Ultragenyx secured its first gene therapy approval, the FDA clearing GENGLYCOS as the first treatment designed to address underlying cause of GSDla.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.